App Note explains the power of anti-idiotype antibodies

16 February 2022
Posted in News, Trending News | Tagged ,

Assessing the safety and efficacy of biotherapeutics is imperative during the drug-development process. In particular, pharmacokinetic (PK) and anti-drug antibody (ADA) assays are conducted to study and evaluate new drug candidates and biosimilars.

For PK/ADA assays, anti-idiotype antibodies (Anti-IDs) are powerful tools to measure the concentration of antibody drugs in patient samples and serve as positive controls for anti-drug antibodies (ADA).

Download this app note to learn more about:

  • The applications of anti-IDs in PK/ADA assays
  • Sino Biological anti-idiotype antibody generation packages
  • Case Study #1: Development of anti-IDs targeting bispecific antibodies (BsAbs)
  • Case Study #2: Generation of anti-IDs targeting scFv/VHH

Download now.

Suggested Reading

"" Why choose Bethyl antibodies for your R&D
10 January 2023
Vials for medical research New anti-evolocumab antibodies could aid drug development
1 September 2022

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free